Trial Profile
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Dose Study of the Effect of Two Dosage Strengths of SYN-010 Compared With Placebo on Breath Methane Production in Breath Methane-Positive Subjects With IBS-C
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Mar 2023
Price :
$35
*
At a glance
- Drugs Lovastatin (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Synthetic Biologics
- 08 May 2019 According to a Synthetic Biologics media release, topline data-readout is expected during the second half of 2019.
- 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week
- 23 May 2016 According to a Synthetic Biologics media release, results from this trial were presented at Digestive Disease Week (DDW 2016).